{"id":"W2967449819","doi":"10.1016/s0140-6736(19)31773-8","title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":376,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"Janssen Scientific Affairs","keywords":"Secukinumab; Medicine; Clinical endpoint; Psoriasis Area and Severity Index; Internal medicine; Clinical trial; Psoriasis; Population; Randomized controlled trial; Psoriatic arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002218327,0.001685791,0.003981037,0.0003422763,0.0003927591,0.001449838,0.0008706233,0.002056279,0.006052388],"category_scores_gemma":[0.002135121,0.0006584548,0.003951412,0.0004398515,0.001087009,0.001074418,0.0004572813,0.003569822,0.0008399808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007535072,"about_ca_system_score_gemma":0.0008010154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001451856,"about_ca_topic_score_gemma":0.003063976,"domain_scores_codex":[0.9992035,0.0003845062,0.00005802518,0.0001237791,0.00007364755,0.0001566539],"domain_scores_gemma":[0.9990141,0.0004157857,0.0002189852,0.00007867057,0.00005991212,0.000212464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9850765,0.0009773059,0.0002896943,0.001276867,0.002066751,0.00003503589,0.00002901227,0.0001569411,0.001055195,0.00009783896,0.0006595586,0.008279226],"study_design_scores_gemma":[0.9820838,0.01410974,0.001431209,0.00008280935,0.001352261,0.00003315694,0.00002021694,0.0001371669,0.0001111109,0.0001353234,0.0004902564,0.00001297637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9525756,0.03540313,0.001108001,0.001798079,0.001886605,0.002038525,0.001693494,0.0001809383,0.003315596],"genre_scores_gemma":[0.9752181,0.01289016,0.001472997,0.002089534,0.0008387573,0.001988834,0.001401616,0.00004699777,0.004052877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006052388,"threshold_uncertainty_score":0.02024722,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04423776972757437,"score_gpt":0.2942113505826859,"score_spread":0.2499735808551115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}